Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.

Revenue
+1.72%
EPS
−27.6%
Free cash flow
−14.4%
Total debt
−4.11%

Quarter to September 2026, against a year earlier

31.73 1.07 −3.26%
Market cap
$2.5B
P/E
17.1×
Fwd P/E
15.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a

Pediatrix Medical Group, Inc. (MD) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Pediatrix Medical Group, Inc. (MD) trades at a P/S ratio of 1.3×. Over the past ten years it has ranged from 0.3× (June 2024) to 3.0× (August 2015); the current reading is higher than 57% of that period. That is above the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.9× 73.03%
FY2024 0.5× 40.48%
FY2023 0.4× (39.19%)
FY2022 0.6× (47.37%)
FY2021 1.2× 0.31%
FY2020 1.2× 21.00%
FY2019 1.0× (42.97%)
FY2018 1.7× 12.19%
FY2017 1.6× (20.02%)
FY2016 1.9× (18.95%)

Quarterly newest first

Period P/S ratio Change
Sep 2026 1.0× (1.62%)
Jun 2026 1.0× 15.19%
Mar 2026 0.9× (4.69%)
Dec 2025 0.9× 27.47%
43 more quarters

Against its own ten years

Low 0.3× High 3.0×
Ten-year median 1.1×
Current reading's percentile 63

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on MD